Gout in Women: Why It Is Different and Often Misdiagnosed

Gout has long been considered a “man’s disease,” but this misconception has led to significant underdiagnosis and misdiagnosis in women. While men are indeed 3-4 times more likely to develop gout during their lifetime, postmenopausal women face risks that rival men, and their symptoms often present differently, leading to delayed diagnosis and treatment.

According to Medscape, estrogen has a mild uricosuric effect, meaning it helps the kidneys flush out uric acid. Gout is therefore unusual in premenopausal women. However, after menopause, as estrogen levels decline dramatically, women’s uric acid levels rise and approach male ranges, significantly increasing their gout risk.

The Estrogen Protection Effect

Before menopause, women’s bodies enjoy natural protection against hyperuricemia through estrogen. This hormone enhances renal uric acid excretion by:

• Inhibiting urate reabsorption in the proximal tubule
• Increasing glomerular filtration rate
• Modulating inflammatory responses that would otherwise trigger crystal deposition

Studies show that premenopausal women have serum uric acid levels approximately 1-1.5 mg/dL lower than age-matched men. This difference disappears within 5-10 years after menopause as estrogen levels decline.

How Gout Presentation Differs in Women

Atypical Joint Involvement

While men typically present with podagra (big toe involvement), women more frequently experience:

Feature	Men	Women
Primary joint affected	First MTP (big toe) – 50%	Ankle, knee, wrist more common
Number of joints involved	Often single joint	Multiple joints more frequently
Upper extremity involvement	Rare initially	More common
Symptom onset	Sudden, dramatic	Often more gradual

Non-Specific Symptoms

Women are more likely to present with symptoms that can be mistaken for:

• Osteoarthritis (especially in finger joints)
• Rheumatoid arthritis
• Bursitis or tendonitis
• “Just arthritis” or “wear and tear”

Why Misdiagnosis Occurs

Clinical Bias

Many healthcare providers still view gout as primarily a male condition. This leads to:

• Not considering gout in the differential diagnosis for women with joint pain
• Attributing symptoms to more “common” female conditions
• Delayed referral to rheumatology

Laboratory Challenges

Importantly, serum uric acid levels may be normal during an acute gout flare in some patients. As noted in medical literature, blood uric acid levels may be normal during an attack, making diagnosis more challenging.

Overlapping Conditions

Women, particularly older women, often have multiple joint issues simultaneously:

• Osteoarthritis in weight-bearing joints and fingers
• Rheumatoid arthritis (which has female predominance)
• Crystal deposition diseases (including calcium pyrophosphate disease – “pseudogout”)

Risk Factors Unique to or More Common in Women

Postmenopausal Status

The single most important risk factor for gout in women is menopause. The average age of gout onset in women is 65-70 years, compared to 40-50 years in men.

Diuretic Use

Women are more likely to be prescribed thiazide diuretics for hypertension, which:

• Decrease renal uric acid excretion
• Increase serum uric acid levels
• Can precipitate gout attacks

Chronic Kidney Disease

CKD is a major risk factor for gout, and women have higher rates of certain kidney conditions that can impair uric acid excretion.

Obesity and Metabolic Syndrome

The prevalence of metabolic syndrome in women with gout is notably high, compounding cardiovascular and joint risks.

Diagnosis Considerations for Women

Joint Aspiration – The Gold Standard

Regardless of sex, definitive diagnosis requires identification of monosodium urate crystals in synovial fluid. This is particularly important in women where clinical presentation may be atypical.

Imaging Studies

• Ultrasound: Can show characteristic “double contour” sign of urate deposition
• CT Scan: Identifies urate deposits and differentiates from calcium pyrophosphate
• MRI: Useful for evaluating soft tissue involvement

Treatment Approaches

Medication Considerations

Treatment principles are similar for men and women, but some considerations apply:

• Allopurinol: First-line ULT per ACR guidelines. Starting with low doses is crucial to prevent hypersensitivity reactions, especially in patients with CKD.
• Febuxostat: FDA-approved alternative, particularly useful in allopurinol-intolerant patients.
• Colchicine: Effective for acute flares and prophylaxis, though dose adjustment may be needed in CKD.

Lifestyle Modifications

Dietary and lifestyle interventions are equally important for women:

• Maintain healthy weight
• Limit alcohol consumption, especially beer
• Reduce fructose-sweetened beverages
• Stay well-hydrated

Conclusion

Gout in women is underrecognized and often misdiagnosed due to atypical presentations and persistent misconceptions. Healthcare providers should maintain a high index of suspicion for gout in postmenopausal women with joint symptoms, and women should advocate for appropriate evaluation including joint aspiration when indicated.

With proper diagnosis and treatment following evidence-based guidelines, women with gout can achieve excellent outcomes and prevent the long-term complications of uncontrolled disease.

Men and women may experience gout differently. Learn about the gender differences in gout.

For diagnosis, see our complete guide to gout lab tests.